{"nctId":"NCT00663858","briefTitle":"Cetrorelix Pamoate in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)","startDateStruct":{"date":"2008-03"},"conditions":["Benign Prostatic Hypertrophy"],"count":420,"armGroups":[{"label":"Cetrorelix 78+78","type":"EXPERIMENTAL","interventionNames":["Drug: Cetrorelix 78+78"]},{"label":"Cetrorelix 78 + Placebo","type":"EXPERIMENTAL","interventionNames":["Drug: Cetrorelix 78 + Placebo"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Other: Placebo"]}],"interventions":[{"name":"Cetrorelix 78+78","otherNames":[]},{"name":"Cetrorelix 78 + Placebo","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Benign Prostatic Hyperplasia, based on medical history\n* Voiding symptoms\n\nExclusion Criteria:\n\n* Urgent need for prostate surgery or prior surgical treatment of the prostate or bladder\n* Major organ dysfunction\n* Eczema (atopic dermatitis) treated during the last 6 months\n* Current or recent treatment with sexual hormone drugs or 5 α reductase inhibitors or botulinum toxin type a (Botox) within the last 6 months prior randomization or with α blockers or saw palmetto within the last 6 weeks prior to randomization\n* Urologic disorders including neurogenic bladder dysfunction due to diabetes mellitus or documented neurologic disorder, urethral stricture disease or history of pelvic radiation therapy\n* History of acute obstructive, infectious, or neurological disorders of the genitourinary tract within the last 3 months","healthyVolunteers":false,"sex":"MALE","minimumAge":"50 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"International Prostate Symptom Score (IPSS)","description":"IPSS score of BPH symptoms based on a patient questionnaire assessing 7 items (incomplete voiding, frequency, intermittency, urgency, weak stream, hesitancy, nocturia) on a scale from 0 (best) to 5 (worst); total overall score range: 0 points (best) to 35 points (worst)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-6.2","spread":"5.68"},{"groupId":"OG001","value":"-5.1","spread":"5.18"},{"groupId":"OG002","value":"-5.7","spread":"6.04"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":8,"n":212},"commonTop":["Influenza"]}}}